JNJ vs. BSX
JNJ (Johnson & Johnson) and BSX (Boston Scientific Corporation) are both stocks. Both are in the Healthcare sector — JNJ in Drug Manufacturers - General, BSX in Medical Devices. Over the past 10 years, JNJ returned 10.46%/yr vs 7.42%/yr for BSX. At a 0.28 correlation, their price movements are largely independent.
Performance
JNJ vs. BSX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, JNJ achieves a 17.68% return, which is significantly higher than BSX's -50.80% return. Over the past 10 years, JNJ has outperformed BSX with an annualized return of 10.46%, while BSX has yielded a comparatively lower 7.42% annualized return.
JNJ
- 1D
- 1.07%
- 1M
- 5.14%
- YTD
- 17.68%
- 6M
- 15.11%
- 1Y
- 57.60%
- 3Y*
- 17.82%
- 5Y*
- 10.94%
- 10Y*
- 10.46%
BSX
- 1D
- -0.55%
- 1M
- -11.59%
- YTD
- -50.80%
- 6M
- -49.33%
- 1Y
- -52.40%
- 3Y*
- -2.85%
- 5Y*
- 1.80%
- 10Y*
- 7.42%
JNJ vs. BSX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
JNJ Johnson & Johnson | 17.68% | 47.48% | -4.81% | -8.58% | 5.97% | 11.44% | 10.82% | 16.22% | -5.13% | 24.43% |
BSX Boston Scientific Corporation | -50.80% | 6.75% | 54.51% | 24.94% | 8.92% | 18.16% | -20.50% | 27.96% | 42.56% | 14.61% |
Correlation
The correlation between JNJ and BSX is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.21 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.17 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.28 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.33 |
Correlation (All Time) Calculated using the full available price history since May 19, 1992 | 0.28 |
The correlation between JNJ and BSX shifts across timeframes, from 0.17 (3 years) to 0.33 (10 years), reflecting how their relationship changes across market environments.
Fundamentals
JNJ:
$588.98B
BSX:
$70.13B
JNJ:
$8.65
BSX:
$2.38
JNJ:
27.85
BSX:
19.74
JNJ:
0.93
BSX:
0.44
JNJ:
6.08
BSX:
3.40
JNJ:
7.25
BSX:
2.71
JNJ:
$96.36B
BSX:
$20.62B
JNJ:
$66.60B
BSX:
$14.52B
JNJ:
$31.62B
BSX:
$4.76B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
JNJ vs. BSX — Risk / Return Rank
JNJ
BSX
JNJ vs. BSX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Johnson & Johnson (JNJ) and Boston Scientific Corporation (BSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| JNJ | BSX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +4.93 | ||
| Sortino ratioReturn per unit of downside risk | +7.21 | ||
| Omega ratioGain probability vs. loss probability | 1.61 | 0.67 | +0.94 |
| Calmar ratioReturn relative to maximum drawdown | 5.28 | -0.93 | +6.21 |
| Martin ratioReturn relative to average drawdown | 15.52 | -2.00 | +17.52 |
Loading charts...
Drawdowns
JNJ vs. BSX - Drawdown Comparison
The maximum JNJ drawdown since its inception was -50.67%, smaller than the maximum BSX drawdown of -89.15%. Use the drawdown chart below to compare losses from any high point for JNJ and BSX.
Loading charts...
Drawdown Indicators
| JNJ | BSX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -50.67% | -89.15% | +38.48% |
Max Drawdown (1Y)Largest decline over 1 year | -10.96% | -56.62% | +45.66% |
Max Drawdown (3Y)Largest decline over 3 years | -15.95% | -56.62% | +40.67% |
Max Drawdown (5Y)Largest decline over 5 years | -18.41% | -56.62% | +38.21% |
Max Drawdown (10Y)Largest decline over 10 years | -27.37% | -56.62% | +29.25% |
Current DrawdownCurrent decline from peak | -2.54% | -56.62% | +54.08% |
Average DrawdownAverage peak-to-trough decline | -11.90% | -38.76% | +26.86% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.72% | 26.23% | -22.51% |
Volatility
JNJ vs. BSX - Volatility Comparison
The current volatility for Johnson & Johnson (JNJ) is 5.47%, while Boston Scientific Corporation (BSX) has a volatility of 15.84%. This indicates that JNJ experiences smaller price fluctuations and is considered to be less risky than BSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| JNJ | BSX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.47% | 15.84% | -10.37% |
Volatility (6M)Calculated over the trailing 6-month period | 12.16% | 32.83% | -20.67% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.94% | 34.77% | -17.83% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.87% | 25.69% | -8.82% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.48% | 27.29% | -8.81% |
Dividends
JNJ vs. BSX - Dividend Comparison
JNJ's dividend yield for the trailing twelve months is around 2.18%, while BSX has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSX Boston Scientific Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
JNJ Johnson & Johnson | 2.18% | 2.48% | 3.40% | 3.00% | 2.52% | 2.45% | 2.53% | 2.57% | 2.74% | 2.38% | 2.73% | 2.87% |
Financials
JNJ vs. BSX - Financials Comparison
This section allows you to compare key financial metrics between Johnson & Johnson and Boston Scientific Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
JNJ vs. BSX - Profitability Comparison
JNJ - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a gross profit of 17.20B and revenue of 24.06B. Therefore, the gross margin over that period was 71.5%.
BSX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a gross profit of 3.61B and revenue of 5.20B. Therefore, the gross margin over that period was 69.4%.
JNJ - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported an operating income of 6.40B and revenue of 24.06B, resulting in an operating margin of 26.6%.
BSX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported an operating income of 1.07B and revenue of 5.20B, resulting in an operating margin of 20.6%.
JNJ - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a net income of 5.24B and revenue of 24.06B, resulting in a net margin of 21.8%.
BSX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a net income of 1.34B and revenue of 5.20B, resulting in a net margin of 25.7%.
Frequently Asked Questions
JNJ and BSX have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BSX has higher volatility (15.84%) compared to JNJ (5.47%). In terms of maximum drawdown, JNJ dropped -50.67% vs BSX's -89.15%.
JNJ currently has the higher Sharpe Ratio (3.42 vs -1.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for JNJ and BSX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer